U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07152236) titled 'Clinical Study on the Safety and Efficacy of B7H3 CAR T Cells in Patients With B7H3 Positive Solid Tumors' on Aug. 26.
Brief Summary: This single-arm, single-center investigator-initiated trial (IIT) evaluates the safety, efficacy, and pharmacodynamic (PD)/pharmacokinetic (PK) profiles of CAR-T cells in patients with advanced solid tumors.
Eligible subjects are followed until 12 months after infusion or until meeting treatment withdrawal criteria, whichever occurs first.
Study Start Date: Aug. 31
Study Type: INTERVENTIONAL
Condition:
Solid Tumors
Intervention:
BIOLOGICAL: CAR-T
Eligible subjects who successfully passed scree...